GSK May See Payor Exit Diabetes Drug Suit On Own Accord
United Benefit Fund, one of four payors who filed a class action alleging GlaxoSmithKline LLC misrepresented the safety of its Avandia diabetes drugs, took one for the team Friday and asked...To view the full article, register now.
Already a subscriber? Click here to view full article